Insights

Immunotherapy Focus Innate Pharma is a pioneer in leveraging therapeutic antibodies to harness the immune system for cancer treatment, presenting a strong opportunity in the immunotherapy market.

Strategic Partnerships The company has major alliances with industry leaders such as Bristol-Myers Squibb, Novo Nordisk, and AstraZeneca, indicating potential collaboration opportunities and access to a broader customer base.

Clinical Data Launches Innate Pharma's regular launch of new clinical data, such as for various antibodies and cell therapies, provides a consistent reason to engage with potential clients and showcase the company's innovative solutions.

NK Cell Engager Progression Progressing the NK cell engager SAR443579 / IPH6101 to Phase 2 trials for blood cancers highlights a significant advancement that can attract interest from healthcare professionals and organizations targeting cancer treatments.

Financial Stability & Growth With a revenue ranging from $50 million to $100 million and a funding of $75 million, Innate Pharma's financial health positions it as a stable partner for potential buyers, investors, or collaborators.

Innate Pharma Tech Stack

Innate Pharma uses 8 technology products and services including FactSet, SAP, Cerner, and more. Explore Innate Pharma's tech stack below.

  • FactSet
    Business Intelligence
  • SAP
    Customer Relationship Management
  • Cerner
    Electronic Health Records
  • Font Awesome
    Font Scripts
  • HTTP/3
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Adobe Creative Suite
    Visualisation Software
  • ShareThis
    Widgets

Media & News

Innate Pharma's Email Address Formats

Innate Pharma uses at least 1 format(s):
Innate Pharma Email FormatsExamplePercentage
first.last@innate-pharma.comJohn.Doe@innate-pharma.com
87%
first@innate-pharma.comJohn@innate-pharma.com
6%
last@innate-pharma.comDoe@innate-pharma.com
4%
flast@innate-pharma.comJDoe@innate-pharma.com
3%

Frequently Asked Questions

Where is Innate Pharma's headquarters located?

Minus sign iconPlus sign icon
Innate Pharma's main headquarters is located at 117, Avenue de Luminy Marseille, Provence-Alpes-Côte d’Azur 13009 FR. The company has employees across 6 continents, including EuropeAsiaNorth America.

What is Innate Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Innate Pharma's main corporate office by phone at +1-212-943-9478. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Innate Pharma's stock symbol?

Minus sign iconPlus sign icon
Innate Pharma is a publicly traded company; the company's stock symbol is IPHA.

What is Innate Pharma's official website and social media links?

Minus sign iconPlus sign icon
Innate Pharma's official website is innate-pharma.com and has social profiles on LinkedIn.

How much revenue does Innate Pharma generate?

Minus sign iconPlus sign icon
As of May 2024, Innate Pharma's annual revenue reached $75M.

What is Innate Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Innate Pharma's SIC code is 7389 - Business Services, Not Elsewhere Classified NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Innate Pharma have currently?

Minus sign iconPlus sign icon
As of May 2024, Innate Pharma has approximately 203 employees across 6 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officers Assistant: T. S.Chief Financial Officer: F. L.Chief Development Officer, Vice President: N. B.. Explore Innate Pharma's employee directory with LeadIQ.

What industry does Innate Pharma belong to?

Minus sign iconPlus sign icon
Innate Pharma operates in the Biotechnology Research industry.

What technology does Innate Pharma use?

Minus sign iconPlus sign icon
Innate Pharma's tech stack includes FactSetSAPCernerFont AwesomeHTTP/3MicrosoftAdobe Creative SuiteShareThis.

What is Innate Pharma's email format?

Minus sign iconPlus sign icon
Innate Pharma's email format typically follows the pattern of . Find more Innate Pharma email formats with LeadIQ.

How much funding has Innate Pharma raised to date?

Minus sign iconPlus sign icon
As of May 2024, Innate Pharma has raised $75M in funding. The last funding round occurred on May 02, 2022.

When was Innate Pharma founded?

Minus sign iconPlus sign icon
Innate Pharma was founded in 1999.
Innate Pharma

Innate Pharma

Biotechnology ResearchProvence-Alpes-Côte d’Azur, France201-500 Employees

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.

Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.

Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.

Section iconCompany Overview

Headquarters
117, Avenue de Luminy Marseille, Provence-Alpes-Côte d’Azur 13009 FR
Phone number
+1-212-943-9478
SIC Code
7389 - Business Services, Not Elsewhere Classified
Stock Symbol
IPHA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1999
Employees
201-500

Section iconFunding & Financials

  • $75M

    Innate Pharma has raised a total of $75M of funding over 8 rounds. Their latest funding round was raised on May 02, 2022.

  • $50M$100M

    Innate Pharma's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $75M

    Innate Pharma has raised a total of $75M of funding over 8 rounds. Their latest funding round was raised on May 02, 2022.

  • $50M$100M

    Innate Pharma's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.